Delivery Order SPE2DB22D2009-SPE2DB24FL9EF
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp's Corporate Office division. The $21,147.99 firm-fixed-price delivery order is for the supply of 4,565,091 units of the prescription medication Vemlidy 25 mg tablets. The contract has a period of performance through July 9, 2024. AmerisourceBergen, one of the largest pharmaceutical distribution companies globally, holds a $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Vemlidy 25 mg tablets. The $34,970.40 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $6,225.21 firm fixed-price delivery order is for the supply of Vemlidy 25 mg tablets. The award has an ultimate completion date of May 3, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company. The $2,596.53 firm fixed price delivery order is for the provision of Vemlidy 25 mg tablets. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that was awarded solely to Amerisourcebergen Drug Corp, serving as the primary contract vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Vemlidy 25 mg tablets. The contract, valued at $10,975.25, is a Delivery Order with a Firm Fixed Price pricing type. The contract has an ultimate completion date of August 27, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities and veterans' hospitals. This...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,072.88, is a delivery order for the drug Vemlidy, a 25 mg tablet supplied in 30-count packages. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,957.98 firm fixed-price delivery order is for the supply of Vemlidy 25 mg tablets. The contract has an ultimate completion date of August 13, 2021 and was awarded on August 12, 2021. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as AmerisourceBergen. The...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $38,351.04 firm-fixed-price delivery order is for the pharmaceutical product Vemlidy 25 mg Tablet, with a completion date of September 1, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,989.18 firm fixed-price delivery order is for the supply of VEMLIDY 25 MG TABLET UU 30S medical products. The award is not designated under any set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $3,093.54 firm fixed price delivery order is for the supply of 4564157400 - Vemlidy 25 mg Tablet, with an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB24FL9EFDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $1,731.02 firm fixed-price delivery order is for Vemlidy 25 mg tablets. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This includes specialty, brand name, generic, and over-the-counter medications, as well as critical care materials. The IDC enables the DLA to efficiently procure essential medical commodities for military treatment programs and facilities globally. The contract does not have a set-aside designation. Amerisourcebergen is a subsidiary of Cencora, Inc., which is the parent company.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 4/15/24 |